Hinge Health
HNGE
115 hedge funds and large institutions have $1.81B invested in Hinge Health in 2025 Q2 according to their latest regulatory filings, with 115 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
140.94% more ownership
Funds ownership: 0% → 140.94% (+141%)
59% less call options, than puts
Call options by funds: $15.2M | Put options by funds: $37M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IHG
Insight Holdings Group
New York
|
+$446M |
| 2 |
Coatue Management
New York
|
+$190M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$55.1M |
| 4 |
VP
Vitruvian Partners
London,
United Kingdom
|
+$50.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$40.8M |
Top Sellers
HNGE Hedge Fund Activity: Q2 2025 in Review
115 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Hinge Health (HNGE) for Q2 2025, worth a combined $1.81B.
Buyers outnumbered sellers: 115 funds opened new HNGE positions and 0 closed out — a net gain of 115 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Insight Holdings Group, opening a new position worth an estimated $446M.
- 115 institutional investors held Hinge Health (HNGE) as of Q2 2025, up from 0 in Q1 2025.
- Funds reported $1.81B of Hinge Health stock for Q2 2025.
- 115 funds opened new Hinge Health positions in Q2 2025 and 0 closed out, a net change of +115 holders.
- The largest Hinge Health buyer in Q2 2025 was Insight Holdings Group, an estimated $446M added.
Based on aggregated 13F filings for Q2 2025.